DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Farlow M, Anand R, Messina Jr J, Hartman R, Veach J.
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.
Eur Neurol 2000;
44 (04) 236-241
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.